Drugplain

Collajoint Lidocaine Pain Relief Gel Patch 4 g/1001

Lidocaine Pain Relief Gel Patch · PATCH · Henan Enokon Medical Instrument Co., Ltd.

No Recall HistoryCurrently in Shortage
Plain English

Collajoint Lidocaine Pain Relief Gel Patch is a patch containing lidocaine pain relief gel patch at 4 g/1001, taken topical. Manufactured by Henan Enokon Medical Instrument Co., Ltd..

Key Facts

Brand Name
Collajoint Lidocaine Pain Relief Gel Patch
Generic Name
Lidocaine Pain Relief Gel Patch
NDC Code (Product)
83559-012
Manufacturer
Henan Enokon Medical Instrument Co., Ltd.
Strength
4 g/1001
Dosage Form
PATCH
Route
TOPICAL
Marketing Status
Application #
M017
Drug Class
Amide Local Anesthetic [EPC]; Antiarrhythmic [EPC]
Marketing Start
12/01/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

application site vesicles2 reports
application site rash1 reports
erythema multiforme1 reports
rash1 reports
swelling1 reports
therapy cessation1 reports

Frequently Asked Questions

What is Collajoint Lidocaine Pain Relief Gel Patch used for?

Collajoint Lidocaine Pain Relief Gel Patch contains Lidocaine Pain Relief Gel Patch. It is a patch taken topical. Consult your doctor for specific uses.

Is Collajoint Lidocaine Pain Relief Gel Patch a controlled substance?

Collajoint Lidocaine Pain Relief Gel Patch is not classified as a controlled substance by the DEA.

What is the generic name for Collajoint Lidocaine Pain Relief Gel Patch?

The generic name for Collajoint Lidocaine Pain Relief Gel Patch is Lidocaine Pain Relief Gel Patch. There are no other listed brand versions of Lidocaine Pain Relief Gel Patch.

What is the NDC code for Collajoint Lidocaine Pain Relief Gel Patch 4 g/1001?

The NDC (National Drug Code) for Collajoint Lidocaine Pain Relief Gel Patch 4 g/1001 is 83559-012, listed by Henan Enokon Medical Instrument Co., Ltd..

Product NDC

83559-012

Package NDC

83559-012-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)